RecruitingNot ApplicableNCT05799326

Safety and Efficacy of Levofloxacin for Acute Ischemic Stroke

Safety and Efficacy of Levofloxacin for Acute Ischemic Stroke: A Randomized Controlled Clinical Trial

Sponsor

Yi Yang

Enrollment

100 participants

Start Date

Jun 30, 2023

Study Type

INTERVENTIONAL

Conditions

Acute Ischemic Stroke

Summary

The purpose of this study is to determine the efficacy and safety of levofloxacin in treating acute ischemic stroke.

Eligibility

Min Age: 18 YearsMax Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Levofloxacin and a drug called Levofloxacin simulant for people with acute ischemic stroke. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 75 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGLevofloxacin

Levofloxacin is a quinolone antibiotics and newly identified neuro-protective agent.

DRUGLevofloxacin simulant

Levofloxacin simulant is placebo.

Locations(1)

First Hospital of Jilin University

Changchun, Jilin, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05799326

Related Trials

Hyperbaric Oxygen After Stroke Thrombectomy: A Multicenter Randomized Trial on Safety and Efficacy

NCT070496922 locations

A Study to Test if Tenecteplase Helps People to Recover From an Acute Stroke When Given More Than 4.5 Hours After the Person Was Last Seen Well

NCT07361302246 locations

REal-world Clinical evAulation of Medtronic NeurOVascular Products for Acute Ischemic Stroke (RECANOVA Registry)

NCT075999042 locations

Randomized Clinical Trial of Endovascular Therapy for Acute Ischemic Stroke With Occlusion of the M2 Segment of Middle Cerebral Artery

NCT073476653 locations

Efficacy and Safety of Intravenous Thrombolysis in Branch Atheromatous Disease

NCT072999948 locations